The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-7-((2R,4R,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid (2-cyano-ethyl)-amide ID: ALA609079
PubChem CID: 135976483
Max Phase: Preclinical
Molecular Formula: C15H18N6O6
Molecular Weight: 378.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#CCCNC(=O)c1cn(C2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)nc(O)c12
Standard InChI: InChI=1S/C15H18N6O6/c16-2-1-3-18-12(25)6-4-21(11-8(6)13(26)20-15(17)19-11)14-10(24)9(23)7(5-22)27-14/h4,7,9-10,14,22-24H,1,3,5H2,(H,18,25)(H3,17,19,20,26)/t7-,9-,10-,14?/m1/s1
Standard InChI Key: YXUXYEZGVKQCJA-FBFHGVSZSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
6.4750 -6.5167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4750 -5.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6917 -6.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6917 -5.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6500 -8.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9625 -5.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9750 -6.6792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9750 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4125 -8.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2625 -5.4417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9750 -7.7167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2625 -6.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5750 -8.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3000 -8.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -4.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1125 -1.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8542 -2.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1792 -3.7917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9167 -9.6667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5500 -6.6792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9750 -4.2042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5375 -4.2292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -9.6750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6000 -3.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5250 -7.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0250 -8.6167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7917 -3.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 6 2 0
3 1 1 0
4 3 1 0
5 1 1 0
6 1 1 0
7 3 2 0
8 4 2 0
9 5 1 0
10 12 2 0
11 5 1 0
12 7 1 0
13 9 1 0
14 11 1 0
15 2 1 0
16 17 3 0
17 24 1 0
18 15 2 0
9 19 1 6
20 12 1 0
21 8 1 0
22 15 1 0
13 23 1 6
24 27 1 0
14 25 1 1
26 25 1 0
27 22 1 0
4 2 1 0
13 14 1 0
8 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.35Molecular Weight (Monoisotopic): 378.1288AlogP: -2.03#Rotatable Bonds: 5Polar Surface Area: 199.77Molecular Species: NEUTRALHBA: 11HBD: 6#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.02CX Basic pKa: 1.97CX LogP: -2.06CX LogD: -2.06Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.32Np Likeness Score: 0.04
References 1. Saito Y, Umezawa K, Kato K. (1997) Synthesis of echiguanine analogs and their ribofuranosyl glycosides that inhibit phosphatidylinositol 4-kinase, 7 (7): [10.1016/S0960-894X(97)00122-4 ]